EUVIMEDScopri EUVIMED
Open access

SMARCA4 regulates the NK-mediated killing of senescent cells

Virinder Reen iD, Mariantonietta D'Ambrosio, Pia Pernille Søgaard iD, Katie Tyson iD, Bryony J Leeke iD, Isabelle Clément, Isabel C A Dye iD, Joaquim Pombo, Adam Kuba iD, Yemin Lan iD, Joanna Burr iD, Ida C Bomann iD and 14 more

Science Advances · 2025-01-17 · 11 (3)

DOI: 10.1126/sciadv.adn2811 ↗

At a glance

Journal article in Science Advances, published on 2025-01-17. Written by Virinder Reen and 25 co-authors. Institution: MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK. Major MEDLINE topics: Killer Cells, Natural, Cellular Senescence, Transcription Factors, DNA Helicases. Cited 26 times so far (Crossref); 80 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust, Medical Research Council.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Induction of senescence by chemotherapeutic agents arrests cancer cells and activates immune surveillance responses to contribute to therapy outcomes. In this investigation, we searched for ways to enhance the NK-mediated elimination of senescent cells. We used a staggered screen approach, first identifying siRNAs potentiating the secretion of immunomodulatory cytokines to later test for their ability to enhance NK-mediated killing of senescent cells. We identified that genetic or pharmacological inhibition of SMARCA4 enhanced senescent cell elimination by NK cells. SMARCA4 expression is elevated during senescence and its inhibition derepresses repetitive elements, inducing the SASP via activation of cGAS/STING and MAVS/MDA5 pathways. Moreover, a PROTAC targeting SMARCA4 synergized with cisplatin to increase the infiltration of CD8 T cells and mature, activated NK cells in an immunocompetent model of ovarian cancer. Our results indicate that SMARCA4 inhibitors enhance NK-mediated surveillance of senescent cells and may represent senotherapeutic interventions for ovarian cancer.

Subjects

MeSH terms (MEDLINE)

Killer Cells, NaturalCellular SenescenceTranscription FactorsDNA HelicasesNuclear ProteinsHumansFemaleCell Line, TumorAnimalsMiceOvarian NeoplasmsNucleotidyltransferasesCisplatinSignal TransductionCD8-Positive T-Lymphocytes

Substances

SMARCA4 protein, humanTranscription FactorsDNA HelicasesNuclear ProteinsNucleotidyltransferasesCisplatin

Authors and institutions

  • MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK.
  • Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
  • Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) et Institut du Cancer de Montréal, Montreal, QC, Canada.
  • Département de Radiologie, Radio-oncologie et Médicine Nucléaire, Université de Montréal, Montreal, QC, Canada.
  • Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic.

ORCID profiles: Virinder Reen, Pia Pernille Søgaard, Katie Tyson, Bryony J Leeke, Isabel C A Dye, Adam Kuba, Yemin Lan, Joanna Burr, Ida C Bomann, Maria Kalyva, Jodie Birch, Sanjay Khadayate, George Young, Diane Provencher, Anne-Marie Mes-Masson, Santiago Vernia, Hugh J M Brady, Francis Rodier, Raffaella Nativio, Michelle Percharde, Iain A McNeish, Jesús Gil

Funding

  • Wellcome Trust
  • Medical Research Council

Cite

APA

Reen, V., D'Ambrosio, M., Søgaard, P. P., Tyson, K., Leeke, B. J., Clément, I., Dye, I. C. A., Pombo, J., Kuba, A., Lan, Y., Burr, J., Bomann, I. C., Kalyva, M., Birch, J., Khadayate, S., Young, G., Provencher, D., Mes-Masson, A. M., Vernia, S., …, & Gil, J. (2025). SMARCA4 regulates the NK-mediated killing of senescent cells. Science Advances, 11(3). https://doi.org/10.1126/sciadv.adn2811

Vancouver

Reen V, D'Ambrosio M, Søgaard PP, Tyson K, Leeke BJ, Clément I, et al. SMARCA4 regulates the NK-mediated killing of senescent cells. Science Advances. 2025;11(3). doi:10.1126/sciadv.adn2811

BibTeX
@article{Reen2025,
  author = {Reen, Virinder and D'Ambrosio, Mariantonietta and Søgaard, Pia Pernille and Tyson, Katie and Leeke, Bryony J and Clément, Isabelle and Dye, Isabel C A and Pombo, Joaquim and Kuba, Adam and Lan, Yemin and Burr, Joanna and Bomann, Ida C and Kalyva, Maria and Birch, Jodie and Khadayate, Sanjay and Young, George and Provencher, Diane and Mes-Masson, Anne-Marie and Vernia, Santiago and McGranahan, Nicholas and Brady, Hugh J M and Rodier, Francis and Nativio, Raffaella and Percharde, Michelle and McNeish, Iain A and Gil, Jesús},
  title = {SMARCA4 regulates the NK-mediated killing of senescent cells},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {3},
  doi = {10.1126/sciadv.adn2811}
}
Start for free →